NASDAQ · Financial Statements
ERYTECH Pharma S.A. (ERYP) Financial Statements
$0.78
NASDAQ: ERYP
Market Cap $47.38M
Overview Financials Dividend ERYTECH Pharma S.A. most recently reported annual revenue of $0, net profit of $0. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2018 2019 2020 2021 2022 Revenue $4.0M $3.0M $0 $0 $0 Operating Profit $4.0M $5.0M $-69.0M $-57.0M $-3.0M Net Profit $-38.0M $-63.0M $-73.0M $-54.0M $0 EPS $-2.13 $-3.49 $-3.99 $-2.27 $-0.01 Op Margin 107.5% 157.1% — — —
Balance Sheet (USD)
Metric 2018 2019 2020 2021 2022 Total Assets $168.0M $119.0M $80.0M $67.0M $46.0M Total Liabilities $22.0M $33.0M $54.0M $44.0M $22.0M Cash $134.0M $73.0M $44.0M $34.0M $39.0M Borrowings $2.0M $14.0M $27.0M $25.0M $14.0M
Cash Flow (USD)
Metric 2018 2019 2020 2021 2022 Operating Cash Flow $-39.0M $-43.0M $-52.0M $-57.0M $-32.0M Investing Cash Flow $-29.0M $-40.0M $-3.0M $-1.0M $38.0M Financing Cash Flow $-1.0M $0 $25.0M $45.0M $-2.0M Net Cash Flow $-51.0M $-61.0M $-29.0M $-11.0M $5.0M Free Cash Flow $-53.0M $-63.0M $-53.0M $-57.0M $-32.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.27 EV / EBITDA 3.55 FCF Yield -76.85% Quick Ratio 3.54 Interest Coverage -2.05 Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .